Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
MSD Animal Health has further built on the label of Bravecto (fluralaner) in Europe, with the product now approved to treat mite infestations in dogs.
Subscribers have five weeks to nominate their company and innovations as part of the Animal Pharm Awards for 2019.
Merck Animal Health's Bravecto Plus topical solution can now be used for cats in the US following FDA approval.
Boehringer Ingelheim Animal Health has invested nearly $50 million in the extension of its manufacturing site in Barceloneta, Puerto Rico.
Merck Animal Health is currently working on the development of a triple-action antiparasitic for pets – a potential blockbuster product.
Alivira Animal Health has gained WHO-Geneva approval for the manufacture of praziquantel-based anthelmintics at its facility in Vizag.
Elanco has received a supplemental approval from the US FDA for its Credelio antiparasitic that adds a preventative indication to the product.
A new study by MSD Animal Health has highlighted new data on the impact of Exzolt – a parasiticide for poultry red mite infestations.
Norwegian firm Pharmaq has introduced Alpha Flux – its bath treatment for prevention of sea lice infestation in salmonids – to the Chilean market.
Boehringer Ingelheim Vetmedica has gained additional marketing authorizations for several of its leading pet antiparasitics in Europe.
Zoetis claims the biggest markets for its upcoming triple-combination antiparasitic Simparica Trio will be the US, Japan and Australia.
Zoetis has gained positive efficacy data for its Simparica Trio antiparasitic pipeline candidate.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.